Candel Therapeutics unveils $80M public offering
Portfolio Pulse from
Candel Therapeutics Inc (NASDAQ:CADL) has announced an $80 million underwritten public offering of its common stock and pre-funded warrants, including 10 million shares at $6 per share and 3.33 million pre-funded warrants at $5.99 each.
December 13, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Candel Therapeutics is conducting an $80 million public offering, which may lead to stock price fluctuations due to increased share supply.
The $80 million public offering increases the supply of shares, which can lead to a decrease in stock price due to dilution. The offering price of $6 per share is a key factor for investors to consider. The pre-funded warrants also add to the potential dilution effect.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100